Cholinergic Urticaria - Efficacy of Dupilumab

NCT03749148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Cholinergic Urticaria

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]